A series of sulfonyl-N-hydroxyguanidine derivatives was designed and synthesized for cytotoxic evaluation as potential anticancer agents on the basis of the lead compound LY- 181984. Replacement of the ureido moiety of the lead compound with hydroxyguanidine ...